Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 808.5 JPY 2.31% Market Closed
Market Cap: 642.5B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Rohto Pharmaceutical Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rohto Pharmaceutical Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Rohto Pharmaceutical Co Ltd
TSE:4527
Cash from Investing Activities
-ÂĄ91.5B
CAGR 3-Years
-216%
CAGR 5-Years
-73%
CAGR 10-Years
-21%
Shiseido Co Ltd
TSE:4911
Cash from Investing Activities
-ÂĄ70.8B
CAGR 3-Years
-1%
CAGR 5-Years
13%
CAGR 10-Years
-15%
Kao Corp
TSE:4452
Cash from Investing Activities
-ÂĄ89.1B
CAGR 3-Years
-12%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
Kose Corp
TSE:4922
Cash from Investing Activities
-ÂĄ13.6B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
2%
F
Fancl Corp
TSE:4921
Cash from Investing Activities
-ÂĄ2.1B
CAGR 3-Years
38%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Cash from Investing Activities
-ÂĄ26.4B
CAGR 3-Years
-45%
CAGR 5-Years
-43%
CAGR 10-Years
-14%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
640.7B JPY
Industry
Consumer products

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Intrinsic Value
3 343.8 JPY
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Rohto Pharmaceutical Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-91.5B JPY

Based on the financial report for Sep 30, 2024, Rohto Pharmaceutical Co Ltd's Cash from Investing Activities amounts to -91.5B JPY.

What is Rohto Pharmaceutical Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-21%

Over the last year, the Cash from Investing Activities growth was -466%. The average annual Cash from Investing Activities growth rates for Rohto Pharmaceutical Co Ltd have been -216% over the past three years , -73% over the past five years , and -21% over the past ten years .

Back to Top